Pathological circuit function is at the origin of many symptoms of neurological disorders. The optogenetic toolbox applied to animal models of behavioral diseases has in the last years led to decisive progress with the hope that deep brain stimulation may be used for rational treatments.
OptoDBS 2019 will discuss the state of the art of current therapies for DBS and ask how a better understanding of neural circuit dysfunction in pathology could inspire novel protocols. A particular emphasis will be on novel DBS indications such as obsessive compulsive disorders (OCD), depression or addiction. Cutting-edge optogenetic presentations will interleave with clinical studies from leading experts.
We are extremely thankful to the sponsors for their generous support, which has allowed us to have a program with a line-up of distinguished invited speakers. In addition, slots remain available for talks selected from the abstracts.
Students and post-docs are invited to apply for travel awards, again made available by our sponsors.The accreditation of continuing education for animal experimentation (1-2 days) is requested from the Swiss Association of Cantonal Veterinarians.